NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Javelin Biotech

Javelin Biotech

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://javelinbiotech.com/

Last Round

Grant

Jun 16, 2026

Total Funding Raised

$4.73M

Company Overview

Javelin Biotech is a biotechnology company that develops predictive drug discovery platforms merging human tissue chips with computational biology and machine learning to improve preclinical R&D productivity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware + Subscription, Data as a Service

AI Layer

Application

Keywords

organ-on-a-chipmicrophysiological systemsMPSpreclinical drug discoverydigital twinpharmacokineticsPKADMEin vitro testinganimal-free testingdrug development platformperfusion controllertissue chippredictive toxicologybiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Javelin Biotech Comps

Public and private peers based on sector, stage, and business model.

Javelin Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Javelin Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 16, 2026
GrantAug 30, 2023
GrantAug 18, 2022
GrantSep 21, 2021
SeedSep 3, 2019

Key People

Founding team and executive leadership

Murat Cirit

CEO & Co-Founder

Founding Team

Javelin Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 21, 2021

    Secured $260K from NIH RADx.

Javelin Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Javelin Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Javelin Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Employee Range7
Year Founded2019
Last FundingJun 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.